{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:08:16Z","timestamp":1740143296212,"version":"3.37.3"},"reference-count":92,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T00:00:00Z","timestamp":1686182400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA261842"],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA261842"],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["R21EB031982"],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"Implementation of effective cancer treatment strategies requires consideration of how the spatiotemporal heterogeneities within the tumor microenvironment (TME) influence tumor progression and treatment response. Here, we developed a multi-scale three-dimensional mathematical model of the TME to simulate tumor growth and angiogenesis and then employed the model to evaluate an array of single and combination therapy approaches. Treatments included maximum tolerated dose or metronomic (i.e., frequent low doses) scheduling of anti-cancer drugs combined with anti-angiogenic therapy. The results show that metronomic therapy normalizes the tumor vasculature to improve drug delivery, modulates cancer metabolism, decreases interstitial fluid pressure and decreases cancer cell invasion. Further, we find that combining an anti-cancer drug with anti-angiogenic treatment enhances tumor killing and reduces drug accumulation in normal tissues. We also show that combined anti-angiogenic and anti-cancer drugs can decrease cancer invasiveness and normalize the cancer metabolic microenvironment leading to reduced hypoxia and hypoglycemia. Our model simulations suggest that vessel normalization combined with metronomic cytotoxic therapy has beneficial effects by enhancing tumor killing and limiting normal tissue toxicity.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1011131","type":"journal-article","created":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T17:28:44Z","timestamp":1686245324000},"page":"e1011131","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["Computational simulations of tumor growth and treatment response: Benefits of high-frequency, low-dose drug regimens and concurrent vascular normalization"],"prefix":"10.1371","volume":"19","author":[{"given":"Mohammad R.","family":"Nikmaneshi","sequence":"first","affiliation":[]},{"given":"Rakesh K.","family":"Jain","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0698-7232","authenticated-orcid":true,"given":"Lance L.","family":"Munn","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2023,6,8]]},"reference":[{"issue":"8","key":"pcbi.1011131.ref001","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1073\/pnas.1700340114","article-title":"Role of vascular normalization in benefit from metronomic chemotherapy.","volume":"114","author":"F Mpekris","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"pcbi.1011131.ref002","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nrclinonc.2016.64","article-title":"Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect.","volume":"13","author":"G Bocci","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"pcbi.1011131.ref003","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.biomaterials.2018.08.007","article-title":"Metronomic oral doxorubicin in combination of Chk1 inhibitor MK-8776 for p53-deficient breast cancer treatment","volume":"182","author":"SW Chung","year":"2018","journal-title":"Biomaterials"},{"issue":"2","key":"pcbi.1011131.ref004","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10456-016-9503-z","article-title":"The differential effects of metronomic gemcitabine and antiangiogenic treatment in patient-derived xenografts of pancreatic cancer: treatment effects on metabolism, vascular function, cell proliferation, and tumor growth.","volume":"19","author":"DT Yapp","year":"2016","journal-title":"Angiogenesis"},{"key":"pcbi.1011131.ref005","article-title":"Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapy","author":"F Mpekris","year":"2022","journal-title":"Journal of Controlled Release"},{"key":"pcbi.1011131.ref006","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.canlet.2017.02.005","article-title":"The potential clinical promise of \u2019multimodality\u2019 metronomic chemotherapy revealed by preclinical studies of metastatic disease.","volume":"400","author":"RS Kerbel","year":"2017","journal-title":"Cancer Lett"},{"issue":"40","key":"pcbi.1011131.ref007","doi-asserted-by":"crossref","first-page":"42396","DOI":"10.18632\/oncotarget.6377","article-title":"Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer","volume":"6","author":"T Di Desidero","year":"2015","journal-title":"Oncotarget"},{"issue":"9","key":"pcbi.1011131.ref008","doi-asserted-by":"crossref","first-page":"e11416","DOI":"10.15252\/emmm.201911416","article-title":"Metronomic chemotherapy offsets HIFalpha induction upon maximum-tolerated dose in metastatic cancers","volume":"12","author":"L Schito","year":"2020","journal-title":"EMBO Mol Med"},{"issue":"17","key":"pcbi.1011131.ref009","doi-asserted-by":"crossref","first-page":"5656","DOI":"10.1158\/1078-0432.CCR-11-0078","article-title":"Metronomic oral topotecan with pazopanib is an active antiangiogenic regimen in mouse models of aggressive pediatric solid tumor","volume":"17","author":"S Kumar","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"6","key":"pcbi.1011131.ref010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrclinonc.2015.89","article-title":"Gastrointestinal cancer: Rationale for metronomic chemotherapy in phase III trials","volume":"12","author":"RS Kerbel","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"pcbi.1011131.ref011","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10456-012-9260-6","article-title":"Clinical, pharmacokinetic and pharmacodynamic evaluations of metronomic UFT and cyclophosphamide plus celecoxib in patients with advanced refractory gastrointestinal cancers.","volume":"15","author":"G Allegrini","year":"2012","journal-title":"Angiogenesis"},{"issue":"12","key":"pcbi.1011131.ref012","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14122906","article-title":"ChemoSensitivity Assay Guided Metronomic Chemotherapy Is Safe and Effective for Treating Advanced Pancreatic Cancer.","volume":"14","author":"WH Isacoff","year":"2022","journal-title":"Cancers (Basel)."},{"issue":"5","key":"pcbi.1011131.ref013","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1593\/tlo.13481","article-title":"Metronomic chemotherapy: possible clinical application in advanced hepatocellular carcinoma.","volume":"6","author":"T Torimura","year":"2013","journal-title":"Transl Oncol."},{"issue":"10","key":"pcbi.1011131.ref014","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11102783","article-title":"Metronomic Chemotherapy for Advanced Prostate Cancer: A Literature Review.","volume":"11","author":"S Parshad","year":"2022","journal-title":"J Clin Med"},{"issue":"11","key":"pcbi.1011131.ref015","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1002\/1097-0142(19820601)49:11<2231::AID-CNCR2820491105>3.0.CO;2-1","article-title":"High-frequency low-dose multiple-drug chemotherapy in advanced metastatic breast cancer","volume":"49","author":"A Berken","year":"1982","journal-title":"Cancer"},{"key":"pcbi.1011131.ref016","first-page":"1","article-title":"A Mechanistic Review of Methotrexate and Celecoxib as a Potential Metronomic Chemotherapy for Oral Squamous Cell Carcinoma.","author":"MV Kamal","year":"2022","journal-title":"Cancer Invest"},{"issue":"6","key":"pcbi.1011131.ref017","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1002\/hed.27044","article-title":"Maintenance metronomic chemotherapy for metastatic\/recurrent nasopharyngeal carcinoma.","volume":"44","author":"CW Twu","year":"2022","journal-title":"Head Neck"},{"issue":"4","key":"pcbi.1011131.ref018","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s10388-022-00923-8","article-title":"Oral metronomic chemotherapy after definitive chemoradiation in esophageal squamous cell carcinoma: a randomized clinical trial","volume":"19","author":"V Noronha","year":"2022","journal-title":"Esophagus"},{"issue":"12","key":"pcbi.1011131.ref019","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1038\/bjc.1996.295","article-title":"A randomised trial of low-dose\/high-frequency chemotherapy as palliative treatment of poor-prognosis small-cell lung cancer: a Cancer research Campaign trial","volume":"73","author":"LE James","year":"1996","journal-title":"Br J Cancer"},{"issue":"6516","key":"pcbi.1011131.ref020","doi-asserted-by":"crossref","first-page":"eaaz0868","DOI":"10.1126\/science.aaz0868","article-title":"Physical traits of cancer","volume":"370","author":"HT Nia","year":"2020","journal-title":"Science"},{"key":"pcbi.1011131.ref021","article-title":"Multiphoton phosphorescence quenching microscopy reveals kinetics of tumor oxygenation during anti-angiogenesis and angiotensin signaling inhibition","author":"JD Martin","year":"2022","journal-title":"Clinical Cancer Research: an Official Journal of the American Association for Cancer Research"},{"issue":"5","key":"pcbi.1011131.ref022","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1073\/pnas.1018154108","article-title":"Scaling rules for diffusive drug delivery in tumor and normal tissues","volume":"108","author":"JW Baish","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"pcbi.1011131.ref023","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1152\/physrev.00038.2010","article-title":"Normalization of the vasculature for treatment of cancer and other diseases","volume":"91","author":"S Goel","year":"2011","journal-title":"Physiol Rev"},{"issue":"4","key":"pcbi.1011131.ref024","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrc778","article-title":"Dissecting tumour pathophysiology using intravital microscopy","volume":"2","author":"RK Jain","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"pcbi.1011131.ref025","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1146\/annurev-physiol-020518-114700","article-title":"Normalizing Function of Tumor Vessels: Progress, Opportunities, and Challenges","volume":"81","author":"JD Martin","year":"2019","journal-title":"Annu Rev Physiol"},{"issue":"4","key":"pcbi.1011131.ref026","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.trecan.2018.02.005","article-title":"Reengineering the physical microenvironment of tumors to improve drug delivery and efficacy: from mathematical modeling to bench to bedside.","volume":"4","author":"T Stylianopoulos","year":"2018","journal-title":"Trends in cancer"},{"issue":"6","key":"pcbi.1011131.ref027","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nnano.2012.45","article-title":"Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner","volume":"7","author":"VP Chauhan","year":"2012","journal-title":"Nature nanotechnology"},{"issue":"5706","key":"pcbi.1011131.ref028","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.1104819","article-title":"Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy","volume":"307","author":"RK Jain","year":"2005","journal-title":"Science"},{"issue":"2\u20133","key":"pcbi.1011131.ref029","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mvr.2007.05.003","article-title":"Tumor microvasculature and microenvironment: targets for anti-angiogenesis and normalization.","volume":"74","author":"D Fukumura","year":"2007","journal-title":"Microvascular research."},{"issue":"6","key":"pcbi.1011131.ref030","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrd3455","article-title":"Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases","volume":"10","author":"P Carmeliet","year":"2011","journal-title":"Nature reviews Drug discovery"},{"issue":"7\u20138","key":"pcbi.1011131.ref031","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1600-0463.2008.01148.x","article-title":"Imaging angiogenesis and the microenvironment","volume":"116","author":"D Fukumura","year":"2008","journal-title":"Apmis"},{"issue":"3","key":"pcbi.1011131.ref032","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1549-8719.2010.00029.x","article-title":"Tumor microvasculature and microenvironment: novel insights through intravital imaging in pre-clinical models","volume":"17","author":"D Fukumura","year":"2010","journal-title":"Microcirculation"},{"issue":"6","key":"pcbi.1011131.ref033","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1158\/0008-5472.CAN-06-4102","article-title":"Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model","volume":"67","author":"RK Jain","year":"2007","journal-title":"Cancer research"},{"issue":"46","key":"pcbi.1011131.ref034","doi-asserted-by":"crossref","first-page":"18784","DOI":"10.1073\/pnas.1116152108","article-title":"Impaired lymphatic contraction associated with immunosuppression","volume":"108","author":"S Liao","year":"2011","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"13","key":"pcbi.1011131.ref035","doi-asserted-by":"crossref","first-page":"4400","DOI":"10.1158\/0008-5472.CAN-04-0752","article-title":"Peritumor lymphatics induced by vascular endothelial growth factor-C exhibit abnormal function","volume":"64","author":"N Isaka","year":"2004","journal-title":"Cancer research"},{"issue":"7","key":"pcbi.1011131.ref036","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1158\/0008-5472.CAN-05-2655","article-title":"Onset of abnormal blood and lymphatic vessel function and interstitial hypertension in early stages of carcinogenesis","volume":"66","author":"J Hagendoorn","year":"2006","journal-title":"Cancer Research"},{"issue":"18","key":"pcbi.1011131.ref037","first-page":"5110","article-title":"Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse","volume":"52","author":"Y Boucher","year":"1992","journal-title":"Cancer research"},{"issue":"5574","key":"pcbi.1011131.ref038","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1126\/science.1071420","article-title":"Lymphatic metastasis in the absence of functional intratumor lymphatics","volume":"296","author":"TP Padera","year":"2002","journal-title":"Science"},{"issue":"1","key":"pcbi.1011131.ref039","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0026-2862(89)90074-5","article-title":"Transport of fluid and macromolecules in tumors. I. Role of interstitial pressure and convection.","volume":"37","author":"LT Baxter","year":"1989","journal-title":"Microvascular research."},{"issue":"22","key":"pcbi.1011131.ref040","first-page":"5451","article-title":"Time-dependent behavior of interstitial fluid pressure in solid tumors: implications for drug delivery","volume":"55","author":"PA Netti","year":"1995","journal-title":"Cancer Res"},{"issue":"10","key":"pcbi.1011131.ref041","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1002\/bit.27863","article-title":"Chemo-mechanistic multi-scale model of a three-dimensional tumor microenvironment to quantify the chemotherapy response of cancer","volume":"118","author":"MR Nikmaneshi","year":"2021","journal-title":"Biotechnology and Bioengineering"},{"issue":"46","key":"pcbi.1011131.ref042","doi-asserted-by":"crossref","first-page":"8831","DOI":"10.1002\/ange.201003142","article-title":"A nanoparticle size series for in vivo fluorescence imaging","volume":"122","author":"Z Popovi\u0107","year":"2010","journal-title":"Angewandte Chemie"},{"issue":"9","key":"pcbi.1011131.ref043","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm0901-987","article-title":"Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy","volume":"7","author":"RK Jain","year":"2001","journal-title":"Nature medicine"},{"issue":"11","key":"pcbi.1011131.ref044","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1158\/0008-5472.CAN-04-0074","article-title":"Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors","volume":"64","author":"RT Tong","year":"2004","journal-title":"Cancer research"},{"issue":"1","key":"pcbi.1011131.ref045","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1158\/1535-7163.MCT-07-0552","article-title":"Antiangiogenic compounds interfere with chemotherapy of brain tumors due to vessel normalization","volume":"7","author":"A Claes","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"pcbi.1011131.ref046","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-chembioeng-061010-114300","article-title":"Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies.","volume":"2","author":"VP Chauhan","year":"2011","journal-title":"Annual review of chemical and biomolecular engineering"},{"issue":"4","key":"pcbi.1011131.ref047","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/jcb.21187","article-title":"Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize","volume":"101","author":"D Fukumura","year":"2007","journal-title":"Journal of cellular biochemistry"},{"issue":"46","key":"pcbi.1011131.ref048","doi-asserted-by":"crossref","first-page":"18632","DOI":"10.1073\/pnas.1318415110","article-title":"Combining two strategies to improve perfusion and drug delivery in solid tumors","volume":"110","author":"T Stylianopoulos","year":"2013","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"17","key":"pcbi.1011131.ref049","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1200\/JCO.2012.46.3653","article-title":"Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers","volume":"31","author":"RK Jain","year":"2013","journal-title":"Journal of Clinical Oncology"},{"issue":"4","key":"pcbi.1011131.ref050","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1088\/0031-9155\/60\/4\/1477","article-title":"Influence of vascular normalization on interstitial flow and delivery of liposomes in tumors.","volume":"60","author":"D Ozturk","year":"2015","journal-title":"Physics in Medicine & Biology."},{"issue":"12","key":"pcbi.1011131.ref051","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nrc.2017.93","article-title":"Transport of drugs from blood vessels to tumour tissue","volume":"17","author":"MW Dewhirst","year":"2017","journal-title":"Nature Reviews Cancer"},{"issue":"12","key":"pcbi.1011131.ref052","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1080\/14728222.2019.1702974","article-title":"Targeting tumor interstitial fluid pressure: will it yield novel successful therapies for solid tumors?","volume":"23","author":"LC B\u00f6ckelmann","year":"2019","journal-title":"Expert Opinion on Therapeutic Targets"},{"issue":"1","key":"pcbi.1011131.ref053","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s10456-019-09691-z","article-title":"Vessel co-option in glioblastoma: emerging insights and opportunities.","volume":"23","author":"G Seano","year":"2020","journal-title":"Angiogenesis"},{"issue":"9","key":"pcbi.1011131.ref054","doi-asserted-by":"crossref","first-page":"e1005724","DOI":"10.1371\/journal.pcbi.1005724","article-title":"Quantifying the effects of antiangiogenic and chemotherapy drug combinations on drug delivery and treatment efficacy","volume":"13","author":"S Yonucu","year":"2017","journal-title":"PLoS computational biology"},{"issue":"2","key":"pcbi.1011131.ref055","doi-asserted-by":"crossref","first-page":"e0149422","DOI":"10.1371\/journal.pone.0149422","article-title":"A mathematical model coupling tumor growth and angiogenesis.","volume":"11","author":"J Xu","year":"2016","journal-title":"PloS one"},{"issue":"7","key":"pcbi.1011131.ref056","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1073\/pnas.1818322116","article-title":"Experimental and computational analyses reveal dynamics of tumor vessel cooption and optimal treatment strategies","volume":"116","author":"C Voutouri","year":"2019","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"pcbi.1011131.ref057","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mvr.2019.01.005","article-title":"Image-based spatio-temporal model of drug delivery in a heterogeneous vasculature of a solid tumor\u2014Computational approach.","volume":"123","author":"FM Kashkooli","year":"2019","journal-title":"Microvascular research."},{"issue":"6","key":"pcbi.1011131.ref058","doi-asserted-by":"crossref","first-page":"e67025","DOI":"10.1371\/journal.pone.0067025","article-title":"Numerical modeling of interstitial fluid flow coupled with blood flow through a remodeled solid tumor microvascular network","volume":"8","author":"M Soltani","year":"2013","journal-title":"PloS one"},{"issue":"5","key":"pcbi.1011131.ref059","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s10409-007-0098-x","article-title":"Numerical simulation of blood flow and interstitial fluid pressure in solid tumor microcirculation based on tumor-induced angiogenesis","volume":"23","author":"G Zhao","year":"2007","journal-title":"Acta Mechanica Sinica"},{"key":"pcbi.1011131.ref060","doi-asserted-by":"crossref","first-page":"36992","DOI":"10.1038\/srep36992","article-title":"Effects of endothelial cell proliferation and migration rates in a computational model of sprouting angiogenesis","volume":"6","author":"K-A Norton","year":"2016","journal-title":"Scientific reports"},{"key":"pcbi.1011131.ref061","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/978-1-0716-2617-7_14","article-title":"Computational Simulation of Tumor-Induced Angiogenesis.","volume":"2553","author":"M. Sugimoto","year":"2023","journal-title":"Methods Mol Biol"},{"issue":"1","key":"pcbi.1011131.ref062","doi-asserted-by":"crossref","DOI":"10.1088\/2057-1976\/ac4175","article-title":"Capillary network formation and structure in a modified discrete mathematical model of angiogenesis","volume":"8","author":"M. Soltani","year":"2021","journal-title":"Biomed Phys Eng Express"},{"key":"pcbi.1011131.ref063","doi-asserted-by":"crossref","first-page":"111312","DOI":"10.1016\/j.jtbi.2022.111312","article-title":"Multi-scale model of lumen formation via inverse membrane blebbing mechanism during sprouting angiogenesis process","volume":"556","author":"MS Ghasemi Nasab","year":"2023","journal-title":"J Theor Biol"},{"issue":"4","key":"pcbi.1011131.ref064","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jtbi.2010.02.036","article-title":"Three-dimensional multispecies nonlinear tumor growth-II: Tumor invasion and angiogenesis","volume":"264","author":"HB Frieboes","year":"2010","journal-title":"J Theor Biol"},{"issue":"1","key":"pcbi.1011131.ref065","doi-asserted-by":"crossref","first-page":"e83962","DOI":"10.1371\/journal.pone.0083962","article-title":"Computational modeling of 3D tumor growth and angiogenesis for chemotherapy evaluation.","volume":"9","author":"L Tang","year":"2014","journal-title":"PloS one"},{"key":"pcbi.1011131.ref066","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jtbi.2017.02.018","article-title":"How tumour-induced vascular changes alter angiogenesis: Insights from a computational model","volume":"419","author":"A St\u00e9phanou","year":"2017","journal-title":"Journal of theoretical biology"},{"issue":"1","key":"pcbi.1011131.ref067","doi-asserted-by":"crossref","first-page":"e1005259","DOI":"10.1371\/journal.pcbi.1005259","article-title":"A validated multiscale in-silico model for mechano-sensitive tumour angiogenesis and growth","volume":"13","author":"V Vavourakis","year":"2017","journal-title":"PLoS computational biology"},{"issue":"1","key":"pcbi.1011131.ref068","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-27303-6","article-title":"Mathematical modeling of the function of Warburg effect in tumor microenvironment.","volume":"8","author":"M Shamsi","year":"2018","journal-title":"Scientific reports."},{"issue":"1","key":"pcbi.1011131.ref069","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-59658-0","article-title":"A multi-scale model for determining the effects of pathophysiology and metabolic disorders on tumor growth.","volume":"10","author":"MR Nikmaneshi","year":"2020","journal-title":"Scientific reports."},{"key":"pcbi.1011131.ref070","first-page":"1","article-title":"Investigation of cancer response to chemotherapy: a hybrid multi-scale mathematical and computational model of the tumor microenvironment.","author":"MR Nikmaneshi","year":"2022","journal-title":"Biomechanics and Modeling in Mechanobiology"},{"key":"pcbi.1011131.ref071","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.mvr.2018.05.001","article-title":"The pivotal role of angiogenesis in a multi-scale modeling of tumor growth exhibiting the avascular and vascular phases.","volume":"119","author":"H Salavati","year":"2018","journal-title":"Microvasc Res"},{"issue":"6","key":"pcbi.1011131.ref072","doi-asserted-by":"crossref","first-page":"e1009081","DOI":"10.1371\/journal.pcbi.1009081","article-title":"Multiscale modeling of tumor growth and angiogenesis: Evaluation of tumor-targeted therapy.","volume":"17","author":"S Jafari Nivlouei","year":"2021","journal-title":"PLoS Comput Biol"},{"issue":"4","key":"pcbi.1011131.ref073","doi-asserted-by":"crossref","first-page":"e0231137","DOI":"10.1371\/journal.pone.0231137","article-title":"A hybrid model of tumor growth and angiogenesis: In silico experiments.","volume":"15","author":"CM Phillips","year":"2020","journal-title":"PLoS One."},{"key":"pcbi.1011131.ref074","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jconrel.2022.03.008","article-title":"Normalizing tumor microenvironment with nanomedicine and metronomic therapy to improve immunotherapy","volume":"345","author":"F Mpekris","year":"2022","journal-title":"J Control Release"},{"key":"pcbi.1011131.ref075","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1007\/s11538-015-0105-5","article-title":"Two-Phase acto-cytosolic fluid flow in a moving Keratocyte: a 2D continuum model","volume":"77","author":"M Nikmaneshi","year":"2015","journal-title":"Bulletin of mathematical biology"},{"key":"pcbi.1011131.ref076","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jbiomech.2017.11.025","article-title":"Fully-coupled mathematical modeling of actomyosin-cytosolic two-phase flow in a highly deformable moving Keratocyte cell","volume":"67","author":"M Nikmaneshi","year":"2018","journal-title":"Journal of Biomechanics"},{"issue":"6","key":"pcbi.1011131.ref077","doi-asserted-by":"crossref","first-page":"H2206","DOI":"10.1152\/ajpheart.00348.2009","article-title":"Structural adaptation of microvessel diameters in response to metabolic stimuli: where are the oxygen sensors?","volume":"297","author":"B Reglin","year":"2009","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"1","key":"pcbi.1011131.ref078","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1742-7843.2011.00815.x","article-title":"Structural adaptation of normal and tumour vascular networks","volume":"110","author":"TW Secomb","year":"2012","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"pcbi.1011131.ref079","volume-title":"Molecular Cell Biology","author":"A Berk","year":"2000","edition":"4"},{"issue":"1","key":"pcbi.1011131.ref080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1742-4682-6-5","article-title":"FEM-based oxygen consumption and cell viability models for avascular pancreatic islets","volume":"6","author":"P. Buchwald","year":"2009","journal-title":"Theoretical Biology and Medical Modelling"},{"issue":"1","key":"pcbi.1011131.ref081","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","article-title":"The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.","volume":"7","author":"RJ DeBerardinis","year":"2008","journal-title":"Cell metabolism"},{"issue":"1","key":"pcbi.1011131.ref082","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0014-4827(82)90063-5","article-title":"Energy metabolism and ATP turnover time during the cell cycle of Ehrlich ascites tumour cells","volume":"141","author":"S Skog","year":"1982","journal-title":"Experimental cell research"},{"key":"pcbi.1011131.ref083","article-title":"Identification and functional analysis of endothelial tip cell-enriched genes","author":"R del Toro","year":"2010","journal-title":"Blood"},{"issue":"10","key":"pcbi.1011131.ref084","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/ncb2103","article-title":"Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting","volume":"12","author":"L Jakobsson","year":"2010","journal-title":"Nature cell biology"},{"issue":"3","key":"pcbi.1011131.ref085","first-page":"E390","article-title":"Computational modeling of three-dimensional ECM-rigidity sensing to guide directed cell migration","volume":"115","author":"M-C Kim","year":"2018","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"15","key":"pcbi.1011131.ref086","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.15252\/embj.201696150","article-title":"Endothelial cell metabolism in health and disease: impact of hypoxia","volume":"36","author":"BW Wong","year":"2017","journal-title":"The EMBO journal"},{"issue":"9","key":"pcbi.1011131.ref087","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1039\/c2ib20054f","article-title":"Nascent vessel elongation rate is inversely related to diameter in in vitro angiogenesis","volume":"4","author":"LB Wood","year":"2012","journal-title":"Integrative Biology"},{"issue":"2","key":"pcbi.1011131.ref088","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ceb.2012.02.002","article-title":"VEGF signaling inside vascular endothelial cells and beyond","volume":"24","author":"A Eichmann","year":"2012","journal-title":"Current opinion in cell biology"},{"key":"pcbi.1011131.ref089","first-page":"20","article-title":"Metronomic chemotherapy in non-small cell lung cancer","author":"Y Shu","year":"2020","journal-title":"Oncology Letters"},{"issue":"8","key":"pcbi.1011131.ref090","first-page":"2517","article-title":"Studies on the appropriate administration of cisplatin based on pharmacokinetics and toxicity.","volume":"14","author":"K Kitajima","year":"1987","journal-title":"Gan to Kagaku Ryoho Cancer & Chemotherapy."},{"issue":"14_suppl","key":"pcbi.1011131.ref091","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1200\/jco.2004.22.90140.3041","article-title":"Clinical pharmacokinetics of bevacizumab following every 2-or every 3-week dosing","volume":"22","author":"J Gaudreault","year":"2004","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"pcbi.1011131.ref092","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.ccell.2022.05.016","article-title":"The local microenvironment matters in preclinical basic and translational studies of cancer immunology and immunotherapy","volume":"40","author":"WW Ho","year":"2022","journal-title":"Cancer Cell"}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1011131","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,8]],"date-time":"2023-06-08T17:30:19Z","timestamp":1686245419000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1011131"}},"subtitle":[],"editor":[{"given":"Shayn M.","family":"Peirce","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2023,6,8]]},"references-count":92,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1011131","relation":{},"ISSN":["1553-7358"],"issn-type":[{"type":"electronic","value":"1553-7358"}],"subject":[],"published":{"date-parts":[[2023,6,8]]}}}